3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
4
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
10
Head and Neck Neoplasms
8
Neoplasms
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Recurrence
2
Oropharyngeal Neoplasms
2
Lung Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
pembrolizumab
9
Nivolumab
4
Magnetic Resonance Spectroscopy
3
spartalizumab
2
Ipilimumab
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
FAPI-46
2
Drug Therapy
2
Cisplatin
2
zenocutuzumab
1
venetoclax
1
ulixertinib
1
trametinib
1
tislelizumab
1
seribantumab
1
rovalpituzumab tesirine
1
pazopanib
1
neratinib
1
margetuximab
1
lenvatinib
1
entrectinib
1
durvalumab
1
cobimetinib
1
cemiplimab
1
budigalimab
1
bemarituzumab
1
atezolizumab
1
alectinib
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Immunotherapy
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled